ArticleJournal of clinical immunology2021

Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study.

Juthaporn Cowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.